| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-10 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-09 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |